Based on the experimental data we found that, for example, kinases PIK3CG, NEK5, ERK3, NEK2, PIK3CA, PRKCE, CSNK2A2, PIM1, PKN2, and CAMK2D are enriched in non-small lung carcinoma A549 cell line while kinases DYRK1B, PCTK1, HIPK1, ICK, CDKL5, DYRK1A, MAK, ERK8, CLK1, and CLK2 are enriched in prostate carcinoma VCAP cell line. The gene discussed is NEK2; the disease is prostate carcinoma.